Jonathan Ward is a seasoned Medical Director with extensive experience in the pharmaceuticals industry, particularly in Medical Affairs. Currently serving as a Senior Medical Director at Intellia Therapeutics, Inc., they focus on CRISPR gene editing for ATTR Amyloidosis. Jonathan previously worked as a Clinical Pharmacist at Legacy Health System Pharmacy, providing clinical pharmacotherapy in critical care settings. Their background includes a PharmD from the University of Washington and a BS in Biology from the University of Oregon, along with roles in research, pharmacy practice, and medical science liaison positions across various healthcare institutions.
This person is not in any teams
This person is not in any offices